-
Mashup Score: 0EyeWorld Weekly, May 17, 2024 - EyeWorld - 1 day(s) ago
➤ Topline results for investigational first-in-class dry eye drop ➤ Dosing complete in second cohort of Stargardt disease gene therapy trial ➤ Enrollment complete for Phase 2 acute optic neuritis trial ➤ Enrollment complete for Phase 1/2a trial evaluating neovascular AMD therapy ➤ ASCRS news and events
Source: www.eyeworld.orgCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 2Advocacy in medicine - EyeWorld - 2 day(s) ago
In this Government Relations Update, a PGY-1 from the Hamilton Eye Institute shared her experience at the Alliance of Specialty Medicine Legislative Fly-In and how other young eye surgeons can get involved.
Source: www.eyeworld.orgCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0
Owning an ophthalmic practice or ASC is challenging, especially when it comes to billing for cataract and refractive surgery. This Practice Management column covered how to implement a new pricing structure and additional considerations.
Source: www.eyeworld.orgCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 1
Anti-VEGF intravitreal injections may have some effect on the success of glaucoma procedures, and a retina specialist and glaucoma specialist agreed that this is dependent on the patient.
Source: www.eyeworld.orgCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 3A new understanding for ocular dominance - EyeWorld - 11 day(s) ago
One might think that the topic of ocular dominance is simple, set, well understood. But there are some recent findings that might have an impact on the concept and its relevance to lens selection and target setting for monovision and blended vision.
Source: www.eyeworld.orgCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 1EyeWorld Weekly, May 3, 2024 - EyeWorld - 15 day(s) ago
➤ FDA clears fully autonomous, portable AI device for diabetic retinopathy screening ➤ Positive preliminary data for Phase 1/2 trial evaluating gene therapy treatment for X-linked retinoschisis ➤ Dosing in Phase 1/2 trial for allogenic cell therapy for corneal edema ➤ Dosing complete in trial assessing corneal edema therapy ➤ Phase 4 results for mydriasis product reported ➤ Collaboration seeks to commercialize Alzheimer’s detection through retinal imaging ➤ ASCRS news and events
Source: www.eyeworld.orgCategories: General Medicine News, OphthalmologyTweet-
News of the week: FDA clears autonomous, portable AI device for diabetic retinopathy screening, dosing complete in two trials assessing corneal edema therapies, update on X-linked retinoschisis gene therapy, and more. Read all about it in EyeWorld Weekly https://t.co/ywvhR0GbU2 https://t.co/VxkLKC6q4Z
-
-
Mashup Score: 1Being organized can boost your practice - EyeWorld - 16 day(s) ago
Being organized and understanding every component of a practice is not merely helpful, it is essential. This Practice Management column provided a checklist of what needs to be tracked and well organized regularly.
Source: www.eyeworld.orgCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0
Two physicians provided their thoughts on diagnosis of normal tension glaucoma, establishing true progression, and how to manage worsening disease in this patient population
Source: www.eyeworld.orgCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 2EyeWorld Weekly, April 26, 2024 - EyeWorld - 22 day(s) ago
➤ Topline results for investigational diabetic retinopathy therapy ➤ Dosing complete in second cohort for Phase 1/2 trial for geographic atrophy therapy ➤ Large data modules launched for dry eye disease and thyroid eye disease ➤ Study: Real-world outcomes of MIGS combined with cataract surgery vs. cataract surgery alone ➤ ASCRS news and events
Source: www.eyeworld.orgCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 1
Among the important indications for use of the EVO ICL (STAAR Surgical)—age, amount of myopia, astigmatism correction, etc.—there is one parameter that some surgeons say could be causing confusion. Five of these surgeons discussed anterior chamber depth.
Source: www.eyeworld.orgCategories: General Medicine News, OphthalmologyTweet
News of the week: Topline results for investigational first-in-class dry eye drop, dosing update in Stargardt disease therapy trial, trial enrollment updates, and more. Read all about it in EyeWorld Weekly https://t.co/MLYRLF7zqt https://t.co/geOBQC98GK